| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for 600380 from our risk checks.
Joincare Pharmaceutical Group Industry Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥11.97 |
| 52 Week High | CN¥13.25 |
| 52 Week Low | CN¥9.40 |
| Beta | 0.41 |
| 11 Month Change | -1.56% |
| 3 Month Change | 13.78% |
| 1 Year Change | 0.084% |
| 33 Year Change | 1.53% |
| 5 Year Change | 20.67% |
| Change since IPO | 70.51% |
Recent News & Updates
Recent updates
Shareholder Returns
| 600380 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 6.0% | 2.1% | 3.9% |
| 1Y | 0.08% | -5.1% | 5.9% |
Return vs Industry: 600380 exceeded the CN Pharmaceuticals industry which returned -5.1% over the past year.
Return vs Market: 600380 underperformed the CN Market which returned 5.9% over the past year.
Price Volatility
| 600380 volatility | |
|---|---|
| 600380 Average Weekly Movement | 5.2% |
| Pharmaceuticals Industry Average Movement | 7.0% |
| Market Average Movement | 7.8% |
| 10% most volatile stocks in CN Market | 12.0% |
| 10% least volatile stocks in CN Market | 5.3% |
Stable Share Price: 600380 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600380's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 14,365 | Xiong Yu | www.joincare.com |
Joincare Pharmaceutical Group Industry Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals and health care products primarily in China. The company offers chemical preparation for drugs, including digestive tract, cardiovascular and cerebrovascular, antimicrobial, anti-tumor, assisted reproductive, neurological therapeutic, OCT, and other drugs; and traditional Chinese drug preparation production, which includes anti-tumor and cold products.
Joincare Pharmaceutical Group Industry Co.,Ltd. Fundamentals Summary
| 600380 fundamental statistics | |
|---|---|
| Market cap | CN¥22.43b |
| Earnings (TTM) | CN¥1.47b |
| Revenue (TTM) | CN¥15.89b |
15.3x
P/E Ratio1.4x
P/S RatioIs 600380 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600380 income statement (TTM) | |
|---|---|
| Revenue | CN¥15.89b |
| Cost of Revenue | CN¥6.16b |
| Gross Profit | CN¥9.73b |
| Other Expenses | CN¥8.26b |
| Earnings | CN¥1.47b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Nov 25, 2024
| Earnings per share (EPS) | 0.78 |
| Gross Margin | 61.21% |
| Net Profit Margin | 9.25% |
| Debt/Equity Ratio | 22.7% |
How did 600380 perform over the long term?
See historical performance and comparison